INTRODUCTION
Cetiedil, one of a family of compounds synthesized as smooth muscle relaxants, relieves pain from claudication and Raynaud's phenomenon (1) . In addition, cetiedil has been reported to decrease the duration and intensity of sickle cell crises, although this study was not performed in a controlled, double-blinded fashion (2) . This effect may be more than vascular since a statistically significant decrease in sickle forms has also been observed when hemoglobin S-containing erythrocytes are deoxygenated in the presence of cetiedil (1, 3) . Concentrations of cetiedil used in these in vitro studies were comparable to those achieved during in vivo administration (1) . As the action of the drug differs from other antisickling agents, affecting neither the solubility nor the oxygen affinity of hemoglobin S (3), we postulated that cetiedil might exert its beneficial effect by lowering the concentration of hemoglobin S within the erythrocyte.
The viscosity of the erythrocyte interior is largely a function of hemoglobin concentration. Thus, a fall in cell water content impairs erythrocyte deformability (4) . This effect is magnified in the deoxygenated sickle erythrocyte because a rise in cell hemoglobin concentration greatly accelerates the rate at which hemoglobin S polymerizes (5) . There are also several lines of evidence to suggest that the sickle erythrocyte becomes dehydrated in the process of deoxygenation (6) (7) (8) (9) . Finally, in vitro and in vivo evidence indicate that hypotonic conditions, by lowering intracellular hemoglobin S concentration, inhibit the tendency to sickle (10, 11) . For these reasons a drug that increased sodium permeability or inhibited a preexistent tendency for potassium loss would, by preventing cellular dehydration, preserve the deformability of the sickle erythrocyte.
The present studies were designed to test the in vitro effect of cetiedil on ion and water movements across the membranes of normal and sickle erythrocytes. Two effects were found. Passive Na permeability, examined by both net and unidirectional flux studies, is increased. A preexistent tendency for K loss, studied by exposing erythrocytes to conditions known to generate a selective increase in K permeability, ATP depletion followed by Ca exposure (12) , is inhibited by cetiedil. These properties that prevent cellular dehydration offer a potential explanation for the reported antisickling effects of cetiedil.
METHODS
Blood from hematologically normal volunteers or patients with sickle cell anemia who had not been transfused for a minimum of 6 mo was drawn into heparin-rinsed syringes and used within 30 min ofcollection. For experiments evaluating the net flux of Na and K, the plasma and buffy coat were discarded and the remaining cells were washed four times at 10,000 g in 10 vol of a Na wash containing, NaCl 155 mM; Hepes 5 mM; pH 7.4 at 37°C. A small aliquot ofthese cells was reserved for the base-line measurement of Na, K, and water (the "0 time" sample) and the remaining cells were suspended in buffered saline solutions, the composition of which are detailed in the figure legends. For Na, K, and water determination, the washed cells were centrifuged at 40,000 g in specially constructed lucite cell water tubes with a narrow well at the bottom for collection of the cell button. Na and K measurements were performed by flame photometry, on packed, weighed aliquots of the cells. Results were expressed as milliequivalents per kilogram of dry cell solid. The water content was measured by drying a known weight of wet cells to constant weight at 90°C. Details of these procedures have been previously published (13) .
All incubations were carried out at 37°C in stoppered flasks under air in a water-bath shaker set at 100 oscillations/ min over a traverse of 1 in. At the timepoints indicated on the figures, an aliquot of each suspension was removed and centrifuged at 10,000 g. Following removal of the supernatant by aspiration, the cells were washed four times in the Na wash solution and then processed for Na, K, and water content.
The unidirectional movement of Na was evaluated using 22Na. 22Na was obtained as 22NaCl from New England Nuclear, Boston, Mass. The cells were washed four times in 10 vol of Na wash as described above and added to the appropriate solutions. After a 5-min equilibration period at 37°C, 22Na was added in concentration sufficient to give 50,000 dpm. To examine the effect of cetiedil on Ca-dependent K permeability, cells were washed in 10 vol of a K wash containing, KCI 150 mM, Hepes 5 mM; pH 7.4 at 37°C. Measurements of Na, K, and cell water were performed ("fresh" sample), following which ATP depletion was carried out by exposing cells for 60 min at 37°C to a solution containing, KCI 145 mM, Hepes 10 mM, inosine 10 mM, iodoacetate 1 mM; pH 7.4. The cells were again washed in the K wash to remove all traces of the inhibitor, and Na, K, and cell water measurements were done ("0 time" sample). This repeated use of K-rich solutions prevented initiation of K loss during these preparative steps. The cells were then placed in Narich solutions, the composition of which are indicated in the figure legends, and incubated at 37°C. Aliquots of the suspension were removed at certain timepoints, washed with the Na wash, and processed for Na, K, and water content.
The cetiedil used in these studies was provided in powder form by Dr. Gerard Pilley of Innothera Pharmaceuticals, Arcueil, France. It was suspended in a concentrated form in 95% ethanol and an identical volume of the vehicle was added to all control flasks.
Each experiment was carried out with both normal and sickle erythrocytes. shown. Each of these two figures is a representative doseresponse curve using sickle erythrocytes. The patterns ofdoseresponse achieved with normal erythrocytes were the same.
RESULTS
The effect of cetiedil on the ion and water content of erythrocytes during a 24-h net flux study is shown in Fig. 1 (Fig. 2) . At a cetiedil concentration of 0.5 mM, samples could only be obtained up to 6 h after which total hemolysis occurred, making longer incubations invalid.
To investigate further the etiology ofthe Na gain seen at higher concentrations of cetiedil, a 22Na influx was performed. All samples were exposed to 0.1 mM ouabain to eliminate active Na efflux via the Na-K pump.
Concentrations of cetiedil identical to those in Fig. 2 (0.1, 0.25, and 0.5 mM) were used. At 0.1 mM, the Na influx was identical to a control flask where no cetiedil was present. At cetiedil concentrations > 0.1 mM, Na influx was increased in a dose-dependent fashion (Fig. 3) .
The next series of experiments was performed to evaluate the effect of cetiedil on erythrocyte K permeability. Erythrocytes were exposed to in vitro conditions known to produce a selective increase in K permeability. ATP depletion was accomplished with inosine and iodoacetate. After 1-h exposure to the inhibitor, cell ATP levels were < 1%. The erythrocytes were then placed into one ofthree Na solutions: (a) a solution with EGTA, a Ca chelator; (b) a solution with EGTA plus an excess of Ca; or (c) a solution with EGTA, an excess of Ca, and cetiedil 0.1 mM. Na, K, and water content were measured at 30, 60, and 120 min (Fig. 4) in all solutions. A graded dose-response was seen with maximum inhibition of K and water loss at 0.1 mM cetiedil. Little effect was seen at 10 uM cetiedil.
The final experiment tested the ability of cetiedil to inhibit K and water loss once initiated (Fig. 6) . After ATP depletion, all erythrocytes were placed for 60 min in a solution containing an excess of Ca. At the end of this hour, K and water loss had begun. The cells were then divided into two flasks and cetiedil, at a concentra-0 30 60 120 0 30 60 120 0 30 60 TIME (MINUTES) FIGURE 5 The dosage dependency of cetiedil on Ca-mediated K permeability in the erythrocyte. Erythrocytes were incubated for 1 h in a solution containing, KCL 145 mM, Hepes 10 mM, inosine 10 mM, iodoacetate 1 mM; pH 7.5 at 37°C. The erythrocytes were then placed into six flasks in a solution containing, NaCl 150 mM, Hepes 10 mM, EGTA 0.25 mM, CaCl2 2 mM; pH 7.5 at 37°C. Cetiedil was added to each flask at the concentration indicated on the figure.
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L. R. Berkowitz and E. P. Orringer 6 The effect of cetiedil on Ca-mediated K permeability, once initiated, in the erythrocyte. Erythrocytes were incubated for 1 h in a solution containing, KCl 145 mM, Hepes 10 mM, inosine 10 mM, iodoacetate 1 mM; pH 7.5 at 370C. Erythrocytes were next incubated for 1 h in a solution containing, NaCl 150 mM, Hepes 10 mM, EGTA 0.25 mM, CaCl2 2 mM. Erythrocytes were then divided into 2 flasks and 0.1 mM cetiedil added to one flask (dashed line). tion of 0.1 mM, was added to one. Those cells not exposed to cetiedil continued to lose K and water. Unlike the control flask, however, K loss and cell dehydration were abruptly terminated as soon as the erythrocytes were exposed to cetiedil.
DISCUSSION
The foregoing experiments suggest that cetiedil might exert its antisickling effect by preventing an increase in the concentration of cytoplasmic hemoglobin through an influence on erythrocyte ion and water content. Because the concentration of hemoglobin within all erythrocytes is the major determinant of cytoplasmic viscosity, a rise in hemoglobin concentration results in a fall in cell deformability (14) . An increase in hemoglobin concentration exerts a second, particularly deleterious effect upon sickle erythrocytes. In these cells the rate at which hemoglobin S aggregates following deoxygenation is enormously influenced by the cell hemoglobin concentration (5) .
Since hemoglobin is an impermeant species, its intracellular concentration is determined by the water content of the erythrocyte, which in turn is a function of the number of osmotically active particles within the cell. Because K is the major intracellular cation, a permeability defect specific for K and not Na will result in the loss of cellular ions and water (15) . Several lines of evidence suggest that the sickle erythrocyte becomes dehydrated during cycles of deoxygenation and that this loss of cell water with its resultant increase in cytoplasmic viscosity and impaired cellular deformability is the result of K loss (6) (7) (8) (9) . The mechanism by which such an increase in K permeability might develop is less certain. An attractive hypothesis would suggest that repeated cycles of deoxygenation promote the intracellular accumulation of Ca ions (16, 17) . A rise in the Ca content in the erythrocyte is known to cause K loss by creating K-specific channels in the erythrocyte membrane (12, 18) . Data supporting such a sequence of events in the sickle erythrocyte include the following: (a) increased Ca content of the sickle erythrocyte (17, 19) ; (b) loss of K from sickle erythrocytes during deoxygenation (6); and (c) shrinkage of sickle erythrocytes upon deoxygenation. (9) . One could easily envision as the end result of this process, the severely dehydrated, energy-depleted, irreversibly sickled cell (8, 20) .
Unlike other antisickling agents, cetiedil does not appear to interact with hemoglobin S since oxygen Effect of Cetiedil on Erythrocyte Membrane Cation Permeabilityaffinity and solubility remain unchanged (3). The drug, however, exerts two distinct effects on monovalent cation permeability, each of which would tend to prevent cell dehydration. Either effect of cetiedil would inhibit the increase in cell hemoglobin concentration observed in sickle erythrocytes and thus preserve their intrinsic deformability. Such an hypothesis is consistent with the "swelling" noted by Asakura et al. (3) .
It is reasonable to speculate that the mechanism of action of a potential antisickling agent involves a change in erythrocyte membrane permeability rather than a modification of the hemoglobin S molecule. Before assuming clinical relevance for these in vitro studies with cetiedil, however, a similar reduction in cell dehydration must be demonstrated in vivo. Controlled clinical trials, which include these in vivo measurements of erythrocyte cation and water content, will attempt to correlate physiologic effects on the sickle erythrocyte with amelioration of sickle cell crises.
